Medical Care in China

macular degeneration
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Precision ENT diagnosis and treatmentcovers diseases of the nose, ears, throat and head and neck.
Comprehensive ophthalmological treatmentcovers cataracts, glaucoma, and retinal diseases, etc.
Comprehensive oral restorationcovers implants, prosthodontics, and maxillofacial diseases.
Functional reconstruction supportsthe recovery of hearing, vision, and chewing functions.

Condition Guide

About macular degeneration

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

The macula is a crucial area in the center of the retina responsible for fine vision and color perception. Macular degeneration (AMD) is most common in people over 50 years of age and is associated with age, genetics, smoking, and high blood pressure. It is classified into two types: dry (macular atrophy) and wet (choroidal neovascularization). Wet AMD can cause sudden central vision loss and distorted vision. AMD is a leading cause of irreversible blindness in adults; without timely treatment, wet AMD can lead to blindness within months. Anti-VEGF injections have improved prognosis, and gene and cell therapies are offering new hope for patients with dry AMD.

Cutting-edge high-precision diagnostic and treatment technologies

1. High-dose anti-VEGF : High-dose aflibercept is the first anti-VEGF drug that can extend the injection interval to several months, significantly reducing the number of times patients need to go to the hospital and for intravitreal injections, significantly reducing the treatment burden, and is suitable for long-term maintenance treatment of wet age-related macular degeneration with stable efficacy.
2. Intraocular implantable drug delivery device : Ranibizumab intraocular implantable pump continuously and stably releases the drug through an intraocular implantable device, which can replace monthly intravitreal injections, reduce the trauma and risk of intraocular infection caused by repeated punctures, and has made regulatory progress in Europe and the United States, providing a convenient option for those who need long-term treatment.
3. Anti-VEGF gene therapy : Early clinical data from 12 months of intravitreal injection of anti-VEGF gene therapy showed that patients required significantly fewer subsequent anti-VEGF injections after a single injection, which is expected to replace repeated injections in the long term. Several similar gene therapy studies in China are progressing in an orderly manner.
4. AAV gene therapy : A single intravitreal injection of adeno-associated virus-mediated AAV gene therapy can induce continuous expression of anti-VEGF protein in intraocular cells. Phase II studies have shown positive signals, making it one of the most promising frontier directions in wet age-related macular degeneration.
5. Stem cell therapy : Induced pluripotent stem cell-derived retinal pigment epithelial cell (iPSC-RPE) therapy offers a new repair pathway for dry macular atrophy, which was previously untreatable. Early clinical trials have shown promising safety profiles, making it a promising treatment with a bright future.
6. Complement inhibitors : C3 and C5 complement inhibitors delay the progression of macular atrophy in dry macular degeneration by inhibiting the complement overactivation pathway. They have been approved for use in intermediate dry AMD abroad, and related clinical trials are also being actively promoted in China. Postoperative follow-up examinations are required to assess efficacy and safety.

Care Overview

macular degeneration Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Liu Yunsong

Professor and Vice Dean, specializing in prosthodontics and digital diagnosis and treatment

ENT

Research areas: Clinical, teaching and research in prosthodontics, digital restoration, and implant restoration. Cutting-edge technology: Has long been engaged in clinical, teaching, and research work in prosthodontics. Has led 15 national and provincial-level research projects as principal investigator, published over 0 papers as first/corresponding author, including 2 ESI highly cited papers, and was consecutively listed among the top 2% of scientists globally in 2023 and 2024. Has obtained over 30 nati

National Center for Stomatology, Peking University School of Stomatology logo Affiliated Hospital National Center for Stomatology, Peking University School of Stomatology
Xu Gezhi

Chief Physician, Professor, Doctoral Supervisor, Former Director of Ophthalmology

ENT

-Research areas : vitreoretinal diseases, complex fundus surgery, severe ocular trauma; - Areas of expertise: 3D-navigated complex vitreoretinal surgery, repair of macular holes/recurrent retinal detachment; - Areas of expertise: Complex retinal detachment, proliferative diabetic retinopathy, high myopia macular degeneration, severe ocular rupture injury; - Academic Highlights & Core Values: Top domestic fundus surgeon, has completed numerous failed recurrent retinal detachment surgeries at other hospital

Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital) logo Affiliated Hospital Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital)
Zhuo Yehong

Professor, Chief Physician, Doctoral Supervisor, and Leader of Glaucoma Department

ENT

-Research areas : Glaucoma optic nerve protection, hereditary glaucoma, and surgery for refractory glaucoma. - Cutting-edge technology: Glaucoma drainage valve/drainage pin implantation, comprehensive optic nerve protection program for advanced glaucoma. - Areas of expertise: Primary angle-closure/open-angle glaucoma, refractory glaucoma with multiple postoperative relapses, and congenital glaucoma. - Academic Highlights: Led the compilation of the Chinese expert consensus on glaucoma diagnosis and treatm

Zhongshan Ophthalmic Center, Sun Yat-sen University logo Affiliated Hospital Zhongshan Ophthalmic Center, Sun Yat-sen University
Yi Hongliang

Chief Physician, Doctoral Supervisor

ENT

Research areas : obstructive sleep apnea, pharyngeal and head and neck tumors; Cutting-edge technology: Bimaxillary advancement (MMA) surgery for severe OSA; Areas of expertise: Severe snoring, pharyngeal tumors, pediatric snoring; Academic highlights: Leading expert in snoring surgery in China; Core value: Promoting precise OSA obstruction plane assessment to improve the surgical efficacy of severe snoring. Zhang Zhichang Associate Chief Physician, Doctoral Supervisor Research areas : Sacral and deep pel

Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital logo Affiliated Hospital Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital
Liu Yizhi

Representative of the discipline's founders, Level 2 Professor, Chief Physician, Doctoral Supervisor

ENT

-Research areas : ocular stem cells and lens regeneration; pathogenesis and treatment of cataracts. - Cutting-edge technology: Twisting-mode phacoemulsification cataract surgery, bimanual micro-incision phacoemulsification. Human lens regeneration (a major global medical breakthrough in 201). - Areas of expertise: Congenital cataracts, traumatic cataracts, complex cataracts complicated with glaucoma/uveitis, and lens diseases. - Academic Highlights: Executive Director of the Asia-Pacific Academy of Ophtha

Zhongshan Ophthalmic Center, Sun Yat-sen University logo Affiliated Hospital Zhongshan Ophthalmic Center, Sun Yat-sen University
Feng Guodong

Chief Physician, Professor, Doctoral Supervisor, Deputy Director of Department, Leading Person in Otolaryngology

ENT

-Research areas : Middle ear diseases, lateral skull base diseases, comprehensive diagnosis and treatment of tinnitus; - Areas of expertise: Cochlear implantation, ossicular chain reconstruction, and lateral skull base surgery; - Areas of expertise: Chronic otitis media, cholesteatoma, lateral skull base tumors, refractory tinnitus; - Academic Highlights & Core Values: Experts in promoting ear microsurgery techniques, focusing on multimodal comprehensive assessment of tinnitus and establishing individuali

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Patient Stories

See the Next Step Through Patient Journeys

Skeletal Class III Malocclusion - Reshaping Your Smile and Restarting a Confident Life CASE 01
PATIENT JOURNEY

Skeletal Class III Malocclusion - Reshaping Your Smile and Restarting a Confident Life

ENTCosmetic Surgery

Patient records Name: Nguyen Thi Lan Age: 22 years old Nationality: Vietnamese Diagnosis: Skeletal Class III malocclusion (underbite) Treatment Hospital: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Shanghai) Lan, a 22-year-old university student from Hanoi, Vietnam, is about to graduate. Despite her excellent grades, she suffers from severe underbite, which prevents her from smiling confidently and even affects her chewing and pronunciation. She dreams

View case details →
Cholesteatoma Otitis Media - Navigating the Fog and Regaining a New Voice Patient records CASE 02
PATIENT JOURNEY

Cholesteatoma Otitis Media - Navigating the Fog and Regaining a New Voice Patient records

ENT

Patient records Name: Budi Santoso Age: 45 Nationality: Indonesia Diagnosis: Cholesteatoma-type otitis media (involving the ossicular chain) Treatment Hospital: Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai) Budi, a 45-year-old high school music teacher from Jakarta, Indonesia, had been suffering from recurring ear discharge and hearing loss for nearly a year. Worse still, he began to lose his ability to distinguish pitch, a devastating blow to his career. Local doctors diagn

View case details →
Rhegmatogenous retinal detachment (macular involvement) - Redrawing light on a micrometer scale CASE 03
PATIENT JOURNEY

Rhegmatogenous retinal detachment (macular involvement) - Redrawing light on a micrometer scale

ENT

Patient records Name: Arif bin Ismail Age: 58 Nationality: Malaysia Diagnosis: Rhegmatogenous retinal detachment (macular involvement) Treatment Hospital: Zhongshan Ophthalmic Center, Sun Yat-sen University (Guangzhou) Arif, 58, from Kuala Lumpur, Malaysia, is a watch repairer. His world consists of intricate gears and delicate hairsprings, requiring exceptional vision. However, a week ago, a fixed black shadow suddenly appeared in his right eye's field of vision, like a giant curtain obscuring half the s

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.